Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56


Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.

Araujo GN, Pivatto Junior F, Fuhr B, Cassol EP, Machado GP, Valle FH, Bergoli LC, Wainstein RV, Polanczyk CA, Wainstein MV.

Cardiovasc Interv Ther. 2017 May 24. doi: 10.1007/s12928-017-0472-y. [Epub ahead of print]


Syntax Score and Major Adverse Cardiac Events in Patients with Suspected Coronary Artery Disease: Results from a Cohort Study in a University-Affiliated Hospital in Southern Brazil.

Fuchs FC, Ribeiro JP, Fuchs FD, Wainstein MV, Bergoli LC, Wainstein RV, Zen V, Kerkhoff AC, Moreira LB, Fuchs SC.

Arq Bras Cardiol. 2016 Sep;107(3):207-215. doi: 10.5935/abc.20160111. Epub 2016 Aug 8. English, Portuguese.


Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.

Araujo GN, Wainstein MV, McCabe JM, Huang PH, Govindarajulu US, Resnic FS.

J Interv Cardiol. 2016 Oct;29(5):447-453. doi: 10.1111/joic.12315. Epub 2016 Jul 4.


In vitro antibacterial activity of a silicone-based endodontic sealer and two conventional sealers.

Wainstein M, Morgental RD, Waltrick SB, Oliveira SD, Vier-Pelisser FV, Figueiredo JA, Steier L, Tavares CO, Scarparo RK.

Braz Oral Res. 2016;30. pii: S1806-83242016000100216. doi: 10.1590/1807-3107BOR-2016.vol30.0018. Epub 2016 Feb 23.


HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study.

Mossmann M, Wainstein MV, Gonçalves SC, Wainstein RV, Gravina GL, Sangalli M, Veadrigo F, Matte R, Reich R, Costa FG, Bertoluci MC.

Diabetol Metab Syndr. 2015 Nov 14;7:100. doi: 10.1186/s13098-015-0085-5. eCollection 2015.


Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Bertoluci MC, Cé GV, da Silva AM, Wainstein MV, Boff W, Puñales M.

World J Diabetes. 2015 Jun 10;6(5):679-92. doi: 10.4239/wjd.v6.i5.679. Review.


Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.


Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].


Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.


Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators.

N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2.


Neck circumference and central obesity are independent predictors of coronary artery disease in patients undergoing coronary angiography.

Zen V, Fuchs FD, Wainstein MV, Gonçalves SC, Biavatti K, Riedner CE, Fuchs FC, Wainstein RV, Rhoden EL, Ribeiro JP, Fuchs SC.

Am J Cardiovasc Dis. 2012;2(4):323-30. Epub 2012 Oct 25.


Unprotected left main bifurcation restenosis treated with a 2-stent technique.

Wainstein MV, Wainstein RV, Ribeiro JP.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E200-5. doi: 10.1002/ccd.24655. Epub 2012 Oct 15.


Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.

Hackenhaar FS, Martinez D, Medeiros TM, Klein C, Alabarse PV, Wainstein MV, Gonçalves SC, Benfato MS.

Curr Med Chem. 2012;19(25):4359-66.


Obstructive sleep apnea, detected by the Berlin Questionnaire: an associated risk factor for coronary artery disease.

Massierer D, Martinez D, Fuchs SC, Pellin PP, Garcia MS, Zacharias AL, Antunes IF, Wainstein MV, Moreira LB, Ribeiro JP, Fuchs FD.

Cad Saude Publica. 2012 Aug;28(8):1530-8.


Erectile dysfunction and coronary artery disease: an association of higher risk in younger men.

Riedner CE, Rhoden EL, Fuchs SC, Wainstein MV, Gonçalves SC, Wainstein RV, Zago A, Bourscheit F, Katz N, Zago AJ, Ribeiro JP, Fuchs FD.

J Sex Med. 2011 May;8(5):1445-53. doi: 10.1111/j.1743-6109.2011.02224.x. Epub 2011 Mar 2.


Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial.

Fantin Sde S, Wainstein MV, Polanczyk CA, Ledur P, Lazzari CM, Klein C, Hackenhaar FS, Benfato MS, Schaan BD.

J Clin Endocrinol Metab. 2011 Feb;96(2):478-85. doi: 10.1210/jc.2010-0256. Epub 2010 Nov 17.


Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.

de Azevedo Lucio E, Gonçalves SC, Ribeiro JP, Nunes GL, de Oliveira JR, Araujo GN, Wainstein MV.

Inflamm Res. 2011 Feb;60(2):137-42. doi: 10.1007/s00011-010-0247-8. Epub 2010 Sep 17.


Percutaneous mitral valvoplasty: 30 years of experience.

Wainstein MV, Wainstein RV.

Arq Bras Cardiol. 2010 Mar;94(3):273-4, 292-3. English, Portuguese. No abstract available.


An overview of marine biodiversity in United States waters.

Fautin D, Dalton P, Incze LS, Leong JA, Pautzke C, Rosenberg A, Sandifer P, Sedberry G, Tunnell JW Jr, Abbott I, Brainard RE, Brodeur M, Eldredge LG, Feldman M, Moretzsohn F, Vroom PS, Wainstein M, Wolff N.

PLoS One. 2010 Aug 2;5(8):e11914. doi: 10.1371/journal.pone.0011914. Review.

Supplemental Content

Loading ...
Support Center